Overall, these findings may assist clinicians in addressing patients’ concerns regarding the possible but unproven relationship between GLP-1 RA therapy and the occurrence of cancer, as there is no clear indication of an elevated cancer risk with currently available GLP-1 RAs. The gene discussed is GLP1R; the disease is cancer.